Our business is built around our clear purpose: driving change to defeat chronic disease, built upon our heritage of diabetes. To fulfil our purpose, we apply our core capabilities to pioneer the discovery and development of innovative medicines. By making these accessible to patients throughout the world, we aim to lead in all the therapy areas in which we are present, with the ultimate aspiration to prevent and cure disease.
We fundamentally believe that diversity and inclusion drive value for Novo Nordisk by enabling a diverse line of thought, increasing innovation and leading to better and more nuanced decisions and stronger risk-management. In addition, being a strongly values driven organisation, it is simply the right thing to do. These beliefs are core to who we are and an integrated part of the Novo Nordisk Way. You can read more about this in our Diversity & Inclusion policy.
Sharing the data of this period shows our progress so far, as we commit to creating a more diverse, equitable, and inclusive workplace. Transparency in our D&I data and actions is part of that commitment, as we include key workforce data, actions and progress toward our aspirational targets.
Despite the significant progress we have made, we recognise that this is an ongoing journey, and we must continuously challenge ourselves because the more diverse and inclusive we are, the better we can achieve our purpose, to defeat serious chronic diseases, and, ultimately, drive change for good.